This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Wuhan Healthgen Biotechnology Corp.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: **Innovative Contributions of Quan Zhan in Biotechnology**
Introduction
Quan Zhan, an accomplished inventor based in Wuhan, China, has made significant strides in the field of biotechnology with two patents to his name. His pioneering work centers around the preparation and purification of recombinant proteins, which hold immense potential in pharmaceutical applications.
Latest Patents
Quan Zhan's most recent patents include a novel **preparation method and application of high-purity plant-derived recombinant human serum albumin**. This invention provides a method for creating high-purity recombinant human serum albumin, which can serve as a safe and effective substitute for plasma-derived human serum albumin in clinical and pharmaceutical applications. The innovation not only maintains the biological activity of macromolecules but also enhances their effectiveness in therapeutic scenarios.
Another significant patent by Quan Zhan is the **method for separating and purifying recombinant human fibronectin from genetically engineered rice seed**. This method employs a chromatographic technique for extracting and purifying recombinant human fibronectin, achieving a purity greater than 95% with exceptional bioactivity. This approach is cost-effective and scalable for industrial applications, showcasing Quan's commitment to advancing biotechnology solutions.
Career Highlights
Currently, Quan Zhan contributes his expertise at Wuhan Healthgen Biotechnology Corporation, where his research focuses on developing biopharmaceutical products that can cater to various clinical needs. His innovative approaches have positioned him as a notable figure in the biotechnology landscape.
Collaborations
Throughout his career, Quan has worked alongside talented individuals such as Daichang Yang and Jiquan Ou, whose collaborative efforts have further reinforced the research output at Wuhan Healthgen Biotechnology Corporation. Together, they strive to push the boundaries of biotechnological research and product development.
Conclusion
In summary, Quan Zhan's contributions to biotechnology through his patents reflect his dedication to innovation and improvement within the field. His work not only addresses critical health challenges but also paves the way for future advancements in biopharmaceuticals. As he continues to develop his research and collaborate with others, the impact of his inventions is poised to grow significantly.